ABRDN LIFE SCIENCES INVESTORS SHS OF BENEFICIAL INT USD0.01
(NYSE: HQL)

H&Q Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture and environmental management. The Fund invests primarily in securities of public and private companies. The Fund�s investment advisor is Tekla Capital Management LLC.

17.075 s

-0.115 (-0.67%)
Range 16.920 - 17.330   (2.42%)
Open 17.290
Previous Close 17.190
Bid Price 3.800
Bid Volume 47,100
Ask Price 3.810
Ask Volume 76,900
Volume 185,200
Value -
Remark s
Delayed prices. Updated at 06 Dec 2025 04:03.
Data powered by
View All Events

About ABRDN LIFE SCIENCES INVESTORS SHS OF BENEFICIAL INT USD0.01

H&Q Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture and environmental management. The Fund invests primarily in securities of public and private companies. The Fund�s investment advisor is Tekla Capital Management LLC.

Please login to view stock data and analysis